Fig. 3.
Post-acute COVID-19 management and general recommendations/lifestyle changes for cardiovascular manifestations of SARS-CoV-2 infection. PCI: percutaneous coronary intervention; ACE-i/ARB: angiotensin-converting enzyme inhibitors/angiotensin receptor blockers; MI: myocardial infarction; MRI: magnetic resonance imaging; VT: ventricular tachycardia; LVEF: left ventricular ejection fraction; NYHA: New York Heart Association classification; LMWH: low-molecular-weight heparin; DOACs: direct oral anticoagulants; UFH: unfractionated heparin; POTS: postural orthostatic tachycardia syndrome